P-104 - BASELINE CORRECTION IN BIOEQUIVALENCE STUDIES FOR DRUG PRODUCTS CONTAINING AN ENDOGENOUS COMPOUND.

H. Lim, W. Sun, M. Kim, S. Lee; US Food and Drug Administration, Silver Spring, MD, USA.

Presenting Author(s)

Hye Lim Lim, PharmD, RPh

Postdoctoral Fellow
US Food and Drug Administration
Silver Spring, Maryland, United States